The Blog

Hassman Research Institute – A New Option for Your Renal and Hepatic Impairment Studies

With 20+ years of research experience, Hassman Research Institute (HRI) understands patients’ needs and trial designs, and has the state-of-the-art facility to successfully execute your next trial. HRI’s track record on hep C and hepatic and renal impairment trials is excellent, with an over 100% enrollment and completion rate to goal. HRI is a full-time…

Read More

Study suggests low-dose gabapentin has no appreciable next-day effects on simulated driving performance or cognitive function

Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial Click here to view the full study originally published in Wiley Online Library.

Read More

Upcoming Events

We will have Alliance PIs or team members at several upcoming industry meetings including ISCTM, Outsourcing – West Coast, ICOSR, and APA. Please let us know if we can say hello. Click here for meeting dates and locations.

Read More

NeuroCog Trials expands workforce, increases office space at Durham headquarters

NeuroCog Trials increases their 100+ employee staff and office space at the SouthCourt building near Research Triangle Park NeuroCog Trials, the leading cognitive services provider for the clinical trials industry, announced on November 30 that it is significantly expanding its presence at its headquarters in Durham. Construction is currently underway to give NeuroCog Trials the…

Read More

Clinical Trial Centers Alliance – A Smart Choice for your next GENERAL MEDICAL trial

Beyond CNS, Clinical Trial Centers Alliance delivers rapid enrollment and quality data in Phase I-IV General Medical trials at many of its US sites. 

Read More

Alliance Sites and Services at CNS Summit

We’re just back from another successful CNS Summit meeting. See information from Dr. Walling’s presentation about Risk-Based Monitoring. Did you know that Coordinator costs for a typical study have increased from 3.3% of revenue for traditional monitoring visits to 11.5% of revenue for remote monitoring visits? Remote/Risk Based Monitoring  

Read More

See you at CNS Summit 2016

Will we see you at CNS Summit in October? We will have several of our PIs and service partners there. Contact us to arrange time to connect on-site.

Read More

Announcing New Alliance Partner

We are proud and excited to welcome NeuroCog Trials and NCT Linguistics to our Alliance of sites and services. Led by Rich Keefe, Ph.D. and team, NeuroCog is well-known for innovative methods proven to increase the reliability and sensitivity of cognitive assessments and clinical scales in global studies. Proprietary scales include the BAC (Brief Assessment…

Read More

Cognitive Research Corporation at CNS Summit

Our friends Cognitive Research Corporation at last year’s CNS Summit

Read More

Retrotope announces opening of second clinical trial site

Retrotope announces the opening of second clinical trial site,  the Collaborative Neuroscience Network, LLC. (“CNS”) in Long Beach, California, for the ongoing 28-day, first-in-human randomized, double-blind, controlled, ascending dose study of orally dosed RT001 to evaluate the safety, tolerability, pharmacokinetics (PK), disease state, and exploratory endpoints in patients with Friedreich’s ataxia (FA). Click here for more.

Read More
Page 1 of 612 »